Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Novartis
MacroGenics
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Xencor, Inc.
858 Therapeutics, Inc.
Toray Industries, Inc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Klus Pharma Inc.
Theratechnologies